Who Owns BIB?

ProShares - Ultra Nasdaq Biotechnology — Institutional Ownership & 13F Holdings

$81.90

-0.81 (-0.97%)

Market Cap

$68.9M

Shares Outstanding

960,042

Institutional Holders

22

Total Inst. Value

$3.6M

% of Float Held

QoQ Holder Change

+5

Institutional data as of Q1 2025

New Positions

6

Closed Positions

5

Increased

2

Decreased

6

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1IMC-Chicago, LLCNew$1.1M22,406
2SUSQUEHANNA INTERNATIONAL GROUP, LLP$669K13,877
3CITADEL ADVISORS LLC$519K10,766
4Westwood Wealth Management$385K8,000
5Capital Investment Advisors, LLC$336K6,981
6TOTH FINANCIAL ADVISORY CORP$271K5,626
7Tower Research Capital LLC (TRC)$214K4,436
8PNC FINANCIAL SERVICES GROUP, INC.New$48K1,000
9Park Square Financial Group, LLC$15K316
10Laurel Wealth Advisors LLC$14K300

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold BIB?

As of Q1 2025, 22 institutional investors report holding BIB (ProShares - Ultra Nasdaq Biotechnology) in their 13F filings.

Which hedge fund owns the most BIB?

The largest institutional holder of BIB is IMC-Chicago, LLC with $1.1M in shares.

Are institutions buying or selling BIB?

This quarter, 6 institutions opened new positions in BIB and 5 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.